Genetic Testing Solution for Companion Animals myPETGENE™ Launched Simultaneously Worldwide by Macrogen

SEOUL, South Korea–(BUSINESS WIRE)–The precision medicine biotech company Macrogen (CEO Hyon-yong Chong, www.macrogen.com)
(KOSDAQ:038290) announced that it is officially launching worldwide
myPETGENE^TM, a total care solution for companion animals
based on genetic information.
myPETGENE^TM is a customized solution for genetic testing that
provides information on rare genetic disorders that may occur in each
species of animals, individual DNA identification, and breed and gender
verification by analyzing genes of various companion animals such as
dogs, horses, birds, and cats.
myPETGENE^TM is now available at the official website https://www.mypetgene.com/eng.
Customers around the world can easily view the test results online. When
a customer files an application for a test on the myPETGENE^TM
website, Macrogen sends a service kit to the customer. The customer in
turn sends back the service kit with buccal epithelial cells, blood,
hairs, bone fractions and other samples, and tests are quickly
initiated. Test results will then be available on the myPETGENE^TM
website within three days from the arrival of the service kit at
Macrogen. A test certificate is also available upon request.
Guardians of companion animals can predict and manage potential genetic
disorders well in advance through myPETGENE^TM and will be
able to promote adoptions of healthy animals free of genetic disorders.
Moreover, it will be possible to prevent theft or disappearance of
companion animals by using individual identification and breed
information.
myPETGENE^TM
was first introduced in Korea in December 2015 and was received
favorably by professional breeders and guardians of companion animals.
It is drawing particular attention in connection with genetic disorder
testing services. Macrogen presently maintains a strategic cooperative
service contract with the Korea Kennel Federation (President Park
Sang-woo, www.thekkf.or.kr)
and acts as an official partner for the FCI Dog Shows. The breed
management system within the KKF allows registration and management of
genetic information, such as individual identification and blood
relationships, that are tested with myPETGENE^TM .
KKF President Sang-woo Park said, “We hope that myPETGENE^TM will
help us to prevent dogs from being abandoned and look into their
diseases so that its customers worldwide can live healthy lives with
their animals. We also hope that myPETGENE^TM will contribute
to the preservation of pure breed dogs.”
Macrogen CEO Hyon-yong Chong said, “myPETGENE^TM has already
created an impact in Korea and is contributing to the creation of an
advanced culture in living with companion animals. Macrogen will
continue to expand the service scope of myPETGENE^TM by
implementing additional tests of characteristics identification which
allow the identification of obesity, character, intelligence and so
forth of such animals.” He added, “We will seek collaboration with
internationally recognized veterinary schools and animal hospitals to
distribute customized genetic tests worldwide which guardians of
companion animals can find reliable.”
Macrogen has provided genetic and genomic analysis services for
researchers and customers of clinical trials worldwide for the past two
decades and built world-class technology and service know-how. Macrogen
will continue to build on its technology and know-how to expand its
scope of services that utilize genetic information in the daily lives of
general consumers.